Univalor Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Univalor Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9272
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Univalor Inc (Univalor) is a university technology transfer organization that optimizes research outcomes by commercializing the technological innovations of researchers from health centers and academic institutions. The organization provides researcher services such as protecting intellectual property and evaluating the technical feasibility and commercial potential of technology. It also provides developing requests for financing, establishing a development strategy, transferring technology to industries, and creating partnerships. Univalor determines the ideal form of technology transfer such as option, licensing, transfer of knowledge or material, creation of a spin-off company, and others. The organization works with research offices of universities, research laboratories and their affiliated health centers to ensure implementation of technology transfer agreements. Univalor is headquartered in Montreal, Quebec, Canada.

Univalor Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Univalor Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Univalor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Univalor Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Liphorus Pharma Raises USD5.6 Million in Series A Financing 10
Partnerships 11
Univalor Partners with Centre de recherche du Centre hospitalier de l’Universite de Montreal and Neomed Institute 11
Licensing Agreements 12
SemaThera Enters into Licensing Agreement with Univalor 12
Mperia Therapeutics Enters into Licensing Agreement with Univalor 13
Univalor Inc – Key Competitors 14
Univalor Inc – Key Employees 15
Univalor Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Univalor Inc, Pharmaceuticals & Healthcare, Key Facts 2
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Univalor Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Univalor Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Univalor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Liphorus Pharma Raises USD5.6 Million in Series A Financing 10
Univalor Partners with Centre de recherche du Centre hospitalier de l'Universite de Montreal and Neomed Institute 11
SemaThera Enters into Licensing Agreement with Univalor 12
Mperia Therapeutics Enters into Licensing Agreement with Univalor 13
Univalor Inc, Key Competitors 14
Univalor Inc, Key Employees 15

List of Figures
Univalor Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Univalor Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Univalor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Univalor Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Junex Inc (JNX):石油・ガス:M&Aディール及び事業提携情報
    Summary Junex Inc (Junex) is an oil and natural gas exploration company. It carries out oil and natural gas exploration in Canada and the US. In Canada, the company has assets in sedimentary basins in the St. Lawrence Lowlands, on the Gaspe Peninsula, and on Anticosti Island. In the US, Junex holds …
  • Rakuten, Inc. (4755):企業の財務・戦略的SWOT分析
    Rakuten, Inc. (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dignity Health-製薬・医療分野:企業M&A・提携分析
    Summary Dignity Health is a healthcare service provider that offers patient care services. The center provides health care services that include allergy, behavioral health, anesthesiology, cardiology, chronic care, geriatrics, dermatology, emergency medicine, endocrinology, gastroenterology, immunol …
  • University of Wollongong:企業の戦略的SWOT分析
    University of Wollongong - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NETGEAR, Inc.:企業の戦略・SWOT・財務情報
    NETGEAR, Inc. - Strategy, SWOT and Corporate Finance Report Summary NETGEAR, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Institute for Molecular Medicine Finland:製薬・医療:M&Aディール及び事業提携情報
    Summary Institute for Molecular Medicine Finland (FIMM) is a research institute that conducts research activities in the fields of human genomics and personalized medicine. The institute develops diagnostics, treatment and prevention of common health problems using Finnish clinical and epidemiologic …
  • Genome British Columbia:医療機器:M&Aディール及び事業提携情報
    Summary Genome British Columbia (Genome BC) is a non-profit medical research organization that conducts genomics and proteomics research, and offers science and technology solutions. The organization provides prognostic, new diagnostic, and therapeutic tools for use in personalized medicine. It also …
  • DeNA Co Ltd (2432):企業の財務・戦略的SWOT分析
    DeNA Co Ltd (2432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Argon Medical Devices Inc-医療機器分野:企業M&A・提携分析
    Summary Argon Medical Devices Inc (Argon) is a medical device company that manufactures and supplies products for the dialysis and others. The company provides arterial catheters, temporary pacing electrode trays, pulmonary artery and thermodilution catheters, and single lumen central venous cathete …
  • Urenco Ltd:企業の戦略・SWOT・財務分析
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Pengrowth Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pengrowth Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pengrowth Energy Corp (Pengrowth) is an oil and gas company that explores, acquires, develops and produces oil and natural gas reserves. The company's services include development of large accu …
  • Companhia Energetica de Minas Gerais SA (CMIG4):企業の財務・戦略的SWOT分析
    Companhia Energetica de Minas Gerais SA (CMIG4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Georgian Oil and Gas Corp:電力:M&Aディール及び事業提携情報
    Summary Georgian Oil and Gas Corp (GOGC) is an oil and gas corporation that explores, produces, transports, and supplies oil and gas products. The corporation offers services such as oil and gas transportation infrastructure operation, oil and gas pipelines design and construction, pipeline developm …
  • Holtec International Inc:企業の戦略的SWOT分析
    Holtec International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Swagelok Company:企業の戦略・SWOT・財務情報
    Swagelok Company - Strategy, SWOT and Corporate Finance Report Summary Swagelok Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cantex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cantex Pharmaceuticals Inc (Cantex), formerly ParinGenix Inc is a clinical stage biopharmaceutical company that focuses on the development of proprietary pharmaceuticals for the treatment of cancers and other disorders. The company's pipeline products include CX-01, a proprietary combination …
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務分析
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Stantec Inc (STN):電力:M&Aディール及び事業提携情報
    Summary Stantec Inc. (Stantec) is a construction and consulting services company. The company offers architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engin …
  • Fluor Corp (FLR):電力:M&Aディール及び事業提携情報
    Summary Fluor Corp (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other services t …
  • Tiscali Group:企業の戦略・SWOT・財務分析
    Tiscali Group - Strategy, SWOT and Corporate Finance Report Summary Tiscali Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆